Related Experiment Video
Updated: Jan 19, 2026

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
Peripheral neck nerve tumor: A 73-case study and literature review
K Boumaza1, G Michel1, C Salaud2
1Service d'ORL et de Chirurgie Cervico-Faciale, CHU de Nantes Hôtel-Dieu, 1, place A. Ricordeau, BP 1005, 44093 Nantes Cedex 01, France.
Peripheral neck nerve tumors are typically benign, with surgery as the primary treatment. Malignant transformation is rare but aggressive, with specific indicators like neurofibromatosis suggesting increased risk.
Area of Science:
- Neurology
- Oncology
- Radiology
Background:
- Peripheral neck nerve tumors are rare neoplasms.
- Malignant forms are aggressive and difficult to diagnose.
- Benign tumors have low degenerative potential.
Purpose of the Study:
- Evaluate diagnostic and therapeutic management of peripheral neck nerve tumors.
- Identify predictive factors for malignancy.
- Assess surgical timing and outcomes.
Main Methods:
- Retrospective study of 73 patients treated between 1995 and 2015.
- Analysis of clinical presentation, diagnostic imaging (MRI), and treatment strategies.
- Correlation of patient demographics and clinical signs with tumor type and outcome.
Main Results:
- Mean patient age was 44 years.
- Cervical mass was the main symptom; MRI showed T1 hyposignal and T2 hypersignal.
- Surgery was performed in 99% of cases; chemotherapy used for malignant neuroblastic tumors.
- Neurofibromatosis type 1 and sudden mass increase indicated malignancy; age <10 years suggested neuroblastic tumors.
Conclusions:
- Peripheral neck nerve tumors are predominantly benign with low malignant potential.
- Surgery is the preferred treatment after risk-benefit assessment.
- Consensus on optimal surgical timing for these lesions is lacking.
More Related Videos
03:53Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
Published on: March 15, 2024
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024